St. Olav's University Hospital is the hospital in Trondheim, Norway located at Øya. It is part of St. Olavs Hospital Trust that operates all the hospitals in Sør-Trøndelag and thus indirectly state owned.

During the past decade, Hematologisk seksjon, St.Olav Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematologisk seksjon, St.Olav Hospital" #1 collaborator was "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Nordic Cancer Union" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hematologisk seksjon, St.Olav Hospital" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Hematologisk seksjon, St.Olav Hospital" in a lesser frequency.

Most popular intervention types in "Hematologisk seksjon, St.Olav Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "bortezomib" (1 trials) and "pamidronate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematologisk seksjon, St.Olav Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hematologisk seksjon, St.Olav Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hematologisk seksjon, St.Olav Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hematologisk seksjon, St.Olav Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".